The Evolving Landscape of BRAF-Mutated NSCLC in Australia
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Rachel Roberts-Thomson, a Medical Oncologist at The Queen Elizabeth Hospital and Cancer Care Adelaide, leads a panel discussion focusing on the landscape of BRAF-mutated non-small cell lung cancer. Joined by Prof Ahn Myung-ju, a Medical Oncologist at Hanyang University Medical Centre in South Korea as well as Co-chair for the upcoming World Lung Cancer Conference, and A/Prof Adnan Nagrial, a Medical Oncologist at Westmead Hospital in Sydney. The panel discusses the clinical characteristics and incidence of this molecular subset, the critical need for upfront comprehensive genomic testing, key clinical trial data for targeted therapies, and practical strategies for managing treatment-specific side effects like pyrexia syndrome. This episode is sponsored by Pierre Fabre. (00:00) Welcome and Acknowledgement (00:47) Introducing the Topic and Panel (01:56) BRAF Incidence Overview (02:43) Testing Pathways in Australia (06:16) Mutation Classes and Tools (07:47) Korea Testing Perspective (09:03) Pivotal Targeted Therapy Trials (13:33) Choosing First Line Treatment (16:40) Australian Sequencing Approach (20:23) Managing Pyrexia and Toxicities (25:49) Wrap Up Support TOGA Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify. --------------- Connect with TOGA Attend an Event: https://thoraciconcology.org.au/events/ Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membe... Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/suppo... Follow Us LinkedIn: / thoracic-oncology-group-of-australasia X (Twitter): https://x.com/TOGAANZ Instagram: / togaanz YouTube: / @thoracic_oncology --------------- Acknowledgement of Country The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven

Lucy Letby - Professor John Q'Quigley, Statistician - 19 nurses conference

Why cancer patients are flying to China for treatment - Asia Specific podcast, BBC World Service

Watch his reaction when he’s told he’s a GOOD BOY for the first time 🥹

Spine Surgeon Drowns for 30 Minutes —Comes Back With a List

Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies

Top 20 Most Quotable Monty Python Moments

The Iconic Bass Riff That NOBODY Can Play

The French Do Not Care About Work

Thymic Cancer: The Lesser-Known Thoracic Tumours

#36 | Paul Arbon, Grape and wine sector resilience in South Australia

A/Prof Surein Arulananda: A Masterclass in Career Growth

What’s new with Australian Rainfall and Runoff 2019

75 Hacks Chefs Actually Use

City Council Regular Meeting of July 15, 2026

Why Nobody's Eating McDonald's Anymore

Professor Michael Millward: Clinical Insights in Lung Cancer Research

Ivermectin to Treat Cancer? Get the FACTS

91 Year-Old Grandmother Living Alone In A Mountain Village Forgotten By The World

